"The Report EpiCast
Report: Colorectal Cancer - Epidemiology Forecast to 2025 provides
information on pricing, market analysis, shares, forecast, and
company profiles for key industry participants. -
MarketResearchReports.biz"
Colorectal cancer (CRC) is a
cancer that starts in the colon or the rectum (ACS, 2016). CRC is one
of the most common types of cancers diagnosed. For this analysis,
GlobalData epidemiologists defined CRC as a cancer in all sub-sites
of the colon and rectum, using the International Classification of
Diseases, Tenth Revision (ICD-10) codes for CRC (C18-C20). To build
the forecast, GlobalData epidemiologists sourced international and
national cancer databases such as the Cancer Incidence in Five
Continents (CI5) CI5plus data analysis tool; the EUROCARE-5 survival
database; Surveillance, Epidemiology and End Results (SEER); the
German Centre for Cancer Registry (ZfKD); peer-reviewed research
articles; and government publications. The forecast methodology is
consistent across each of the eight markets, thereby allowing for a
meaningful comparison among them.
In 2015, there were 746,590
diagnosed incident cases of CRC in the 8MM. GlobalData
epidemiologists forecast that the diagnosed incident cases in the 8MM
will increase to 913,832 by 2025 at an Annual Growth Rate (AGR) of
2.24%. With the exception of the US and Germany, all markets will see
an increase in the number of cases, at varying AGRs. The 8MM combined
had an estimated 2,582,288 five-year diagnosed prevalent cases of CRC
in 2015. The number of five-year diagnosed prevalent cases will
increase by 22.06% over the next 10 years to 3,151,930 by 2025. Urban
China will have the highest number of diagnosed incident and
five-year diagnosed prevalent cases among the 8MM, as well as the
highest AGR for both data types. The US and Germany are the only
markets that will see a decrease in incidence rate during the
forecast period.
View Report @
http://www.marketresearchreports.biz/analysis/915867
Scope
- The Colorectal Cancer (CRC)
EpiCast Report provides an overview of the risk factors and global
trends of CRC in the eight major markets (8MM) (US, France, Germany,
Italy, Spain, UK, Japan, and China [urban]). It includes a 10-year
epidemiological forecast of the diagnosed incident cases and the
five-year diagnosed prevalent cases of CRC in these markets from
2015-2025. The diagnosed incident cases of CRC are further segmented
by age, sex, stage at diagnosis, and genetic mutations.
- The CRC epidemiology report is
written and developed by Masters- and PhD-level epidemiologists.
- The EpiCast Report is in-depth,
high quality, transparent and market-driven, providing expert
analysis of disease trends in the 8MM.
Get Sample Copy Of This Report
@
Reasons to buy
The CRC EpiCast report will allow
you to -
- Develop business strategies by
understanding the trends shaping and driving the global CRC market.
- Quantify patient populations in
the global CRC market to improve product design, pricing, and launch
plans.
- Organize sales and marketing
efforts by identifying the age groups and sex that present the best
opportunities for CRC therapeutics in each of the markets covered.
- Compare patient population
potentials by genetic mutation and stage at diagnosis.
Table Of Contetnt :
1 Table of Contents 5
1.1 List of Tables 6
1.2 List of Figures 7
2 Epidemiology 8
2.1 Disease Background 8
2.2 Risk Factors and Comorbidities
9
2.3 Global Trends 11
2.3.1 8MM Incidence Trends 11
2.3.2 8MM, Trends in Five-Year
Relative Survival 14
2.4 Forecast Methodology 15
2.4.1 Sources Used Tables 16
2.4.2 Forecast Assumptions and
Methods 20
2.4.3 Sources Not Used 28
2.5 Epidemiological Forecast for
CRC (2015-2025) 29
2.5.1 Diagnosed Incident Cases of
CRC 29
2.5.2 Age-Specific Diagnosed
Incident Cases of CRC 31
2.5.3 Sex-Specific Diagnosed
Incident Cases of CRC 33
2.5.4 Age-Standardized Diagnosed
Incidence of CRC 35
2.5.5 Diagnosed Incident Cases of
CRC by Stage at Diagnosis 36
2.5.6 Type of Genetic Mutation
among Diagnosed Incident Cases of CRC 37
2.5.7 Five-Year Diagnosed
Prevalent Cases of CRC 38
2.6 Discussion 40
2.6.1 Epidemiological Forecast
Insight 40
2.6.2 Limitations of the Analysis
42
2.6.3 Strengths of the Analysis 43
3 Appendix 44
3.1 Bibliography 44
3.2 About the Authors 51
3.2.1 Epidemiologists 51
3.2.2 Reviewers 51
3.2.3 Global Director of Therapy
Analysis and Epidemiology 52
3.3 About GlobalData 53
3.4 About EpiCast 53
3.5 Disclaimer 54
About us
MarketResearchReports.biz
is the most comprehensive collection of market research reports.
MarketResearchReports.Biz services are specially designed to save
time and money for our clients. We are a one stop solution for all
your research needs, our main offerings are syndicated research
reports, custom research, subscription access and consulting
services. We serve all sizes and types of companies spanning across
various industries.
Contact
Mr.
Nachiket
State
Tower
90
Sate Street, Suite 700
Albany,
NY 12207
Tel:
+1-518-621-2074
No comments:
Post a Comment